Pyc Therapeutics Ltd (PYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2010 | 06-2009 | 06-2008 | 06-2007 | 06-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,281 | 3,073 | 3,232 | 3,369 | 2,639 |
| Receivables | 124 | 342 | 60 | 30 | 11 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 66 |
| TOTAL | $1,405 | $3,414 | $3,323 | $3,419 | $2,758 |
| Non-Current Assets | |||||
| PPE Net | 165 | 73 | 196 | 115 | 74 |
| TOTAL | $165 | $73 | $196 | $115 | $74 |
| Total Assets | $1,570 | $3,487 | $3,519 | $3,534 | $2,832 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,238 | N/A | 7 | 10 | 13 |
| Accounts payable and accrued liabilities | 561 | 330 | 260 | 579 | 221 |
| Other current liabilities | 45 | 44 | 90 | N/A | N/A |
| TOTAL | $1,982 | $535 | $814 | $1,337 | $718 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,238 | 1,028 | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | 240 | 145 |
| Other Non-Current Liabilities | 25 | 13 | 10 | 11 | 0 |
| TOTAL | $1,263 | $1,041 | $10 | $11 | $0 |
| Total Liabilities | $3,245 | $1,576 | $824 | $1,349 | $718 |
| Shareholders' Equity | |||||
| Common Shares | 21,973 | 20,093 | 16,676 | 11,710 | 7,820 |
| Retained earnings | -23,426 | -18,853 | -13,981 | -9,513 | -5,706 |
| Other shareholders' equity | 1,015 | 671 | 0 | 0 | 0 |
| TOTAL | $-437 | $1,911 | $2,695 | $2,197 | $2,114 |
| Total Liabilities And Equity | $2,808 | $3,487 | $3,519 | $3,545 | $2,832 |